1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Kedalion Therapeutics, Inc.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2015

Location

Menlo Park CA US

Primary Industry

Medical Devices & Equipment

About

Founded in 2015 and based in California, US, Kedalion Therapeutics, Inc. is an ophthalmic drug company that provides AcuStream™ platform technology that delivers drugs to the eye.
Current Investors
Novartis, Lagunita BioSciences, Novartis Venture Fund

Request a demo to show more

Primary Industry
Medical Devices & Equipment
Sub Industries
Biopharmaceuticals, Optometrists & Opticians Products and Services, Medical Devices & Equipment, Biomaterials
Website
www.kedalionthera.com
Total Amount Raised
Subscriber access only

Deals

Deals Type
LP Direct
Deal Status Target (s) Deal Date Investor(s) Seller(s) Deal size (Mn) Enterprise value (Mn) Post-money valuation (Mn) EBITDA multiple (x) Revenue multiple (x) Lead partner (s)
Completed Kedalion Therapeutics, Inc. 30 Jun 2022
Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.